Filing Flows › National Health Investors (NHI) › Q3 2026 › vs Q2 2026
National Health Investors (NHI) Q3 2026 vs Q2 2026 (quarter over quarter)
National Health Investors's revenue fell $7.8M (-6%) from $121M in Q2 2026 to $113M in Q3 2026. Operating margin 495.9% against 46.2% (+449.7 pts).
National Health Investors, Q3 2026: revenue $113M (+26% year over year), operating margin 495.9%, net earnings $564M, operating cash flow $48.0M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 495.9% | 46.2% | +449.7 pts |
| Net margin | 496.6% | 45.9% | +450.7 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $113M | $121M | −$7.8M | -6% |
| Operating profit | $563M | $56.1M | $507M | +903% |
| Pre-tax earnings | $563M | $56.1M | $507M | +903% |
| Loss borne by minority interests | $311K | $314K | −$3K | -1% |
| Net earnings | $564M | $55.7M | $508M | +912% |
| Income tax | $279K | $732K | −$453K | -62% |
| Depreciation & amortization | $25.8M | $25.5M | $215K | +0.8% |
| Share-based compensation | $1.5M | $2.4M | −$897K | -38% |
| Working capital & other | $543M | $18.6M | $524M | 29× |
| Operating cash flow | $48.0M | $65.0M | −$17.0M | -26% |
Questions
How much did National Health Investors's revenue grow quarter over quarter in Q3 2026?
National Health Investors's revenue fell $7.8M (-6%) from $121M in Q2 2026 to $113M in Q3 2026. Operating margin 495.9% against 46.2% (+449.7 pts).